Americas Gold and Silver Corporation

Fundamentals4.0
Price Action5.0
News Sentiment6.0
AI Rating
4.0

Key Drivers

  • Improving margins
  • Rising leverage
  • Negative cashflow

AI
AI Summary

4.0

USAS has shifted from a pure turn‑around to an event‑driven growth story—operational catalysts (Cosalá scaling, Galena drilling, Crescent restart) can re-rate the stock only if they deliver consecutive positive operating cash flow and materially reduce net debt within 6–12 months; otherwise rising leverage and thin liquidity make dilutive financing or covenant stress the high‑probability downside.

Catalyst
Liquidity
Execution‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

4.0

Key Financial Insights:

  • Improving margins
  • Rising leverage
  • Negative cashflow

USAS shows improving gross margins and a higher cash balance but remains unprofitable with negative FCF, materially higher leverage and possible equity dilution that increase financing and execution risk.

improving
leverage

Price Behavior

5.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Sharp downtrend
  • Near-term support
  • Overhead resistance

Over the last month the chart shows a clear downtrend—price plunged from $7.81 to $5.38 (~−31%) with a sharp leg from a $10.03 peak to $5.38 (~−46%), now sitting near prior lows (~$5.1–$5.4) as support while $8.2–$10.0 becomes overhead resistance, warranting caution until it reclaims resistance or stabilizes above support.

downtrend
Support Level: $5.10–$5.40
Resistance Level: $8.20–$10.00

Rapid drop from $7.81 to $5.38 (≈−31%) with a steep leg from $10.03 to $5.38 (≈−46%) indicating elevated short-term volatility

Sentiment & News

6.0

Key News Insights:

  • Zacks upgrade
  • Record drilling
  • GDXJ inclusion

Americas Gold and Silver (USAS) gained clear momentum in March 2026 — a Zacks upgrade and bullish price targets, a record 64,000m exploration program with multiple high‑grade vein discoveries, and GDXJ inclusion ahead of Q4 results.

Bullish
IndexInclusion

These coordinated operational and market developments should raise investor confidence and liquidity, likely supporting upside as further assay results and Q4 disclosures arrive